Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 5:12 PM View:  | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 3,329 | $6.36 | $21,172.40 | (2%) 218.24K to 214.91K | |
| 17-Sep-24 5:12 PM View: | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 7,500 | -- | -- | 4% 210.74K to 218.24K | |
| 15-Feb-24 6:18 PM View: | C4 Therapeutics, Inc. (CCCC) | 15-Feb-24 | Payment of Exercise | 6,560 | $7.90 | $51,824.00 | (3%) 217.3K to 210.74K | |
| 15-Feb-24 5:08 PM View: | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 103,400 | -- | -- | 91% 113.9K to 217.3K | |
| 31-Aug-23 4:13 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 2,205 | $2.93 | $6,460.65 | (2%) 116.11K to 113.9K | |
| 31-Aug-23 4:13 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 7,500 | -- | -- | 7% 108.61K to 116.11K | |
| 15-Feb-23 4:44 PM View: | C4 Therapeutics, Inc. (CCCC) | 15-Feb-23 | Grant | 81,600 | -- | -- | 302% 27.01K to 108.61K | |
| 01-Feb-23 4:09 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Jan-23 | Payment of Exercise | 4,319 | $7.78 | $33,601.80 | (14%) 31.32K to 27.01K | |
| 01-Feb-23 4:09 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Jan-23 | Option Exercise | 12,500 | -- | -- | 66% 18.82K to 31.32K | |
| 27-May-22 4:15 PM View: | C4 Therapeutics, Inc. (CCCC) | 25-May-22 | Option Exercise | 12,500 | -- | -- | 125% 10.0K to 22.5K | |
| 12-Apr-22 4:05 PM View: | C4 Therapeutics, Inc. (CCCC) | 12-Apr-22 | Private Purchase | 10,000 | $8.40 | $84,000.00 | 100% 0 to 10.0K | |
| 24-Apr-20 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Apr-20 | Payment of Exercise | 1,927 | $45.91 | $88,468.60 | (7%) 26.2K to 24.27K | 9% |
| 24-Apr-20 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Apr-20 | Option Exercise | 5,893 | -- | -- | 29% 20.31K to 26.2K | |
| 15-Apr-20 4:26 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 14-Apr-20 | Payment of Exercise | 1,599 | $40.64 | $64,983.40 | (7%) 21.91K to 20.31K | (3%) |
| 15-Apr-20 4:26 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Apr-20 | Option Exercise | 5,387 | -- | -- | 33% 16.52K to 21.91K | |
| 25-Feb-20 4:27 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 24-Feb-20 | Payment of Exercise | 1,056 | $48.66 | $51,385.00 | (6%) 17.57K to 16.52K | 14% |
| 25-Feb-20 4:27 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-20 | Option Exercise | 3,333 | -- | -- | 23% 14.24K to 17.57K | |
| 19-Feb-20 4:51 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 18-Feb-20 | Payment of Exercise | 886 | $52.01 | $46,080.90 | (6%) 15.13K to 14.24K | 20% |
| 19-Feb-20 4:51 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-20 | Option Exercise | 2,750 | -- | -- | 22% 12.38K to 15.13K | |
| 20-Feb-19 4:05 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 19-Feb-19 | Payment of Exercise | 821 | $58.03 | $47,642.60 | (6%) 13.2K to 12.37K | 28% |
| 20-Feb-19 4:05 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-19 | Option Exercise | 2,750 | -- | -- | 26% 10.45K to 13.2K | |
| 23-Jan-19 4:22 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Jan-19 | Payment of Exercise | 4,555 | $52.82 | $240,595.00 | (30%) 15.0K to 10.45K | 21% |
| 23-Jan-19 4:22 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-19 | Option Exercise | 15,000 | -- | -- | 100% 0 to 15.0K |